FOR IMMEDIATE RELEASE
Contact: Michael Piatt
Atlantis Healthcare USA
July 12, 2021—
Atlantis Healthcare, a pioneer and global leader in health psychology-based patient support programs, has engaged Michael H. Antoni, PhD to provide expertise for their broadened set of digital health solutions focused on cancer and other chronic diseases.
Dr. Antoni is a Sylvester Professor of Psychology, and Psychiatry and Behavioral Sciences at the University of Miami and a member of the Cancer Control program at the Sylvester Comprehensive Cancer Center. He is a Fellow of the Society of Behavioral Medicine and an Associate Editor for Psychology and Health
Amy Parke, US Lead at Atlantis Healthcare, says, “We are very fortunate to be working with Dr. Antoni. Over the last 30 years, he has been researching the psychosocial effects of cancer and its treatment, with a focus on stress management interventions. His deep knowledge in this area will be of immeasurable value to Atlantis—and to patients—as we create a new suite of solutions designed to support this population, including strategies that focus on adherence to therapy.”
Dr. Antoni will be part of Atlantis Healthcare’s clinical advisor team, joining John Weinman, Professor of Psychology as applied to Medicines at King’s College, and Keith Petrie, Professor of Psychological Medicine at the University of Auckland.
“Reducing stress levels in people being treated for cancer and other chronic diseases is associated with improved psychological and physiological adaptation, greater quality of life and better health outcomes well into the survivorship period,” Dr. Antoni says. “I am excited to share my experience and research with Atlantis to help in the development of digital interventions that improve the patient journey.”
A licensed psychologist in the state of Florida, Dr. Antoni earned his PhD in psychology at the University of Miami. He has led multiple NIH-funded efforts testing the effects of cognitive behavioral stress management (CBSM) interventions on psychological adaptation, immune system functioning, and overall health outcomes in women with breast cancer and men with prostate cancer.